M&T Bank Corp Abbott Laboratories Transaction History

M&T Bank Corp

$29.1 Billion
Q2 2024

A detailed history of M&T Bank Corp transactions in Abbott Laboratories stock. As of the latest transaction made, M&T Bank Corp holds 1,033,505 shares of ABT stock, worth $116 Million. This represents 0.37% of its overall portfolio holdings.

Number of Shares

1,033,505

Previous 993,862 3.99%

Holding current value

$116 Million

Previous $113 Million 4.93%

% of portfolio

0.37%

Previous 0.4%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$100.73 - $112.44 $3.99 Million - $4.46 Million	39,643 Added 3.99%	1,033,505 $107 Million
Q1 2024 May 07, 2024	SELL	$109.52 - $120.96 $16.3 Million - $18 Million	-148,932 Reduced 13.03%	993,862 $113 Million
Q4 2023 Feb 06, 2024	BUY	$90.19 - $110.4 $29.4 Million - $36 Million	325,715 Added 39.86%	1,142,794 $126 Million
Q3 2023 Nov 02, 2023	SELL	$95.53 - $114.62 $6.2 Million - $7.43 Million	-64,866 Reduced 7.35%	817,079 $79.1 Million
Q2 2023 Aug 09, 2023	SELL	$100.78 - $112.29 $980,690 - $1.09 Million	-9,731 Reduced 1.09%	881,945 $96.1 Million
Q1 2023 May 11, 2023	SELL	$96.86 - $114.01 $3.41 Million - $4.02 Million	-35,238 Reduced 3.8%	891,676 $90.3 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $3.48 Million - $4.08 Million	36,612 Added 4.11%	926,735 $102 Million
Q4 2022 Feb 13, 2023	BUY	$95.06 - $111.52 $17,015 - $19,962	179 Added 0.02%	926,914 $102 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $1.01 Million - $1.16 Million	-10,390 Reduced 1.15%	890,123 $86.1 Million
Q2 2022 Aug 05, 2022	BUY	$102.07 - $123.37 $12.2 Million - $14.7 Million	119,311 Added 15.27%	900,513 $84.6 Million
Q1 2022 May 09, 2022	BUY	$114.02 - $139.04 $181,291 - $221,073	1,590 Added 0.2%	781,202 $92.5 Million
Q4 2021 Feb 07, 2022	BUY	$115.53 - $141.46 $1.14 Million - $1.4 Million	9,884 Added 1.28%	779,612 $110 Million
Q3 2021 Oct 28, 2021	BUY	$116.66 - $129.06 $3.84 Million - $4.25 Million	32,907 Added 4.47%	769,728 $90.9 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $3.69 Million - $4.35 Million	-34,921 Reduced 4.52%	736,821 $85.4 Million
Q1 2021 May 06, 2021	BUY	$108.84 - $128.23 $235,638 - $277,617	2,165 Added 0.28%	771,742 $92.5 Million
Q4 2020 Feb 12, 2021	SELL	$105.0 - $114.42 $2.06 Million - $2.24 Million	-19,573 Reduced 2.48%	769,577 $84.3 Million
Q3 2020 Nov 06, 2020	BUY	$91.64 - $111.29 $1.1 Million - $1.34 Million	12,045 Added 1.55%	789,150 $85.9 Million
Q2 2020 Jul 29, 2020	SELL	$76.57 - $98.0 $899,927 - $1.15 Million	-11,753 Reduced 1.49%	777,105 $71.1 Million
Q1 2020 May 14, 2020	SELL	$62.82 - $91.86 $597,732 - $874,047	-9,515 Reduced 1.19%	788,858 $62.3 Million
Q4 2019 Feb 07, 2020	SELL	$78.51 - $87.4 $323,461 - $360,088	-4,120 Reduced 0.51%	798,373 $69.3 Million
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $392,504 - $425,597	4,796 Added 0.6%	802,493 $67.1 Million
Q2 2019 Aug 12, 2019	SELL	$72.88 - $85.0 $225,126 - $262,565	-3,089 Reduced 0.39%	797,697 $67.1 Million
Q1 2019 May 15, 2019	SELL	$66.22 - $80.06 $370,103 - $447,455	-5,589 Reduced 0.69%	800,786 $64 Million
Q4 2018 Feb 01, 2019	SELL	$65.56 - $74.27 $730,994 - $828,110	-11,150 Reduced 1.36%	806,375 $58.3 Million
Q3 2018 Nov 09, 2018	BUY	$60.81 - $73.36 $742,672 - $895,945	12,213 Added 1.52%	817,525 $60 Million
Q2 2018 Aug 10, 2018	BUY	$57.57 - $63.54 $619,741 - $684,008	10,765 Added 1.35%	805,312 $49.1 Million
Q1 2018 May 04, 2018	SELL	$56.27 - $63.62 $1.98 Million - $2.24 Million	-35,178 Reduced 4.24%	794,547 $47.6 Million
Q4 2017 Feb 06, 2018	SELL	$53.68 - $57.47 $715,930 - $766,477	-13,337 Reduced 1.58%	829,725 $47.4 Million
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $18,743 - $20,919	390 Added 0.05%	843,062 $45 Million
Q2 2017 Aug 11, 2017	BUY	N/A	842,672	842,672 $41 Million

Others Institutions Holding ABT

# of Institutions

3,135

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

News

Stay updated on M&T Bank Corp with notifications on news.

Account